178 related articles for article (PubMed ID: 33462751)
1. Inhibition of microRNA-17 enhances cisplatin-induced apoptosis of human tongue squamous carcinoma cell.
Sun Y; Nie W; Qiu B; Guo X; Zhang J; Wei J
J Bioenerg Biomembr; 2021 Apr; 53(2):169-176. PubMed ID: 33462751
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
3. miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1.
Fan S; Chen WX; Lv XB; Tang QL; Sun LJ; Liu BD; Zhong JL; Lin ZY; Wang YY; Li QX; Yu X; Zhang HQ; Li YL; Wen B; Zhang Z; Chen WL; Li JS
Cancer Lett; 2015 Jul; 362(2):183-91. PubMed ID: 25843291
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA MPRL Promotes Mitochondrial Fission and Cisplatin Chemosensitivity via Disruption of Pre-miRNA Processing.
Tian T; Lv X; Pan G; Lu Y; Chen W; He W; Lei X; Zhang H; Liu M; Sun S; Ou Z; Lin X; Cai L; He L; Tu Z; Wang X; Tannous BA; Ferrone S; Li J; Fan S
Clin Cancer Res; 2019 Jun; 25(12):3673-3688. PubMed ID: 30885939
[TBL] [Abstract][Full Text] [Related]
5. ROS enhances the cytotoxicity of cisplatin by inducing apoptosis and autophagy in tongue squamous cell carcinoma cells.
Xue DF; Pan ST; Huang G; Qiu JX
Int J Biochem Cell Biol; 2020 May; 122():105732. PubMed ID: 32097729
[TBL] [Abstract][Full Text] [Related]
6. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
7. miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer.
Lin J; Lin Y; Fan L; Kuang W; Zheng L; Wu J; Shang P; Wang Q; Tan J
Biochem Biophys Res Commun; 2016 Apr; 473(2):382-7. PubMed ID: 26946357
[TBL] [Abstract][Full Text] [Related]
8. Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma.
Chen S; Li H; Zhuang S; Zhang J; Gao F; Wang X; Chen W; Song M
J Exp Clin Cancer Res; 2016 Jul; 35(1):123. PubMed ID: 27473117
[TBL] [Abstract][Full Text] [Related]
9. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis.
Fan S; Liu B; Sun L; Lv XB; Lin Z; Chen W; Chen W; Tang Q; Wang Y; Su Y; Jin S; Zhang D; Zhong J; Li Y; Wen B; Zhang Z; Yang P; Zhou B; Liang Q; Yu X; Zhu Y; Hu P; Chu J; Huang W; Feng Y; Peng H; Huang Q; Song E; Li J
Oncotarget; 2015 Jun; 6(17):14885-904. PubMed ID: 25912308
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
Xiong L; Tang Y; Tang J; Liu Z; Wang X
Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
[No Abstract] [Full Text] [Related]
12. PHF20 inhibition promotes apoptosis and cisplatin chemosensitivity via the OCT4‑p‑STAT3‑MCL1 signaling pathway in hypopharyngeal squamous cell carcinoma.
Liu X; Zhang Z; Kan S; Lv Z; Zhou S; Liu X; Jing P; Xu W
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982773
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
14. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
Peng F; Zhang H; Du Y; Tan P
Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
[TBL] [Abstract][Full Text] [Related]
15. In Vitro and In Vivo Analyses Reveal Tumor-Derived Exosome miR-558 Promotes Angiogenesis in Tongue Squamous Cell Carcinoma by Targeting Heparinase.
Ding B; Chen Q; Wu Z; Li X; Ding Y; Wu Q; Han L; Wu H
Technol Cancer Res Treat; 2024; 23():15330338241261615. PubMed ID: 38887096
[TBL] [Abstract][Full Text] [Related]
16. MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4.
Ren W; Wang X; Gao L; Li S; Yan X; Zhang J; Huang C; Zhang Y; Zhi K
Mol Cell Biochem; 2014 May; 390(1-2):253-62. PubMed ID: 24609942
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.
Zhao Z; Wang H; Zhang L; Mei X; Hu J; Huang K
Anticancer Drugs; 2017 Feb; 28(2):187-196. PubMed ID: 27831944
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.
Chen W; Wang P; Lu Y; Jin T; Lei X; Liu M; Zhuang P; Liao J; Lin Z; Li B; Peng Y; Pan G; Lv X; Zhang H; Ou Z; Xie S; Lin X; Sun S; Ferrone S; Tannous BA; Ruan Y; Li J; Fan S
Theranostics; 2019; 9(20):5739-5754. PubMed ID: 31534516
[TBL] [Abstract][Full Text] [Related]
19. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer.
Sayyed AA; Gondaliya P; Mali M; Pawar A; Bhat P; Khairnar A; Arya N; Kalia K
Mol Pharm; 2021 Aug; 18(8):3010-3025. PubMed ID: 34176265
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial miRNA Determines Chemoresistance by Reprogramming Metabolism and Regulating Mitochondrial Transcription.
Fan S; Tian T; Chen W; Lv X; Lei X; Zhang H; Sun S; Cai L; Pan G; He L; Ou Z; Lin X; Wang X; Perez MF; Tu Z; Ferrone S; Tannous BA; Li J
Cancer Res; 2019 Mar; 79(6):1069-1084. PubMed ID: 30659020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
